CURRICULUM VITAE

Robert Mohapatra, M.D., M.P.H., F.A.C.C.

63 Kresson Road, Suite #101
Cherry Hill, NJ 08034
Tel (856) 428-4100
Fax (856) 428-5748

PERSONAL DATA

Date of Birth: 1972

CITIZENSHIP

Citizen of the United States

EDUCATION

Graduate
1997-2001
St. George's University School of Medicine
Grenada, West Indies
Degree: Doctorate in Medicine

1995-1996
The George Washington University
Washington, DC
Degree: Masters of Public Health with a concentration in Health Promotion/Disease Prevention

Undergraduate
1994-1995
Binghamton University
Binghamton, NY
Graduate studies in Biology with a concentration in Immunology

1990-1994
The Johns Hopkins University
The Johns Hopkins University
Degree: Bachelor of Arts in Natural Sciences with concentrations in Biology and Earth Sciences

POSTGRADUATE TRAINING

7/2001-6/2002
Intern - Internal Medicine
University of Massachusetts Medical Center
Worcester, MA

7/2002-7/2004
Resident - Internal Medicine
University of Massachusetts Medical Center
Worcester, MA

7/2004-7/2005
Fellow - Division of Cardiology
Yale-New Haven Hospital
New Haven, CT
Completed one year fellowship in Congestive Heart Failure/Cardiac Transplant

7/2005-6/2008
Fellow - Division of Cardiology
Cornell/Brooklyn Hospital Center
New York, NY

BOARD CERTIFICATION

American Board of Internal Medicine - Internal Medicine
Echocardiography, Level II
Nuclear Cardiology, Level II
Cardiac CT Angiography, Level I

HOSPITAL AFFILIATIONS

Virtua - West Jersey Health System - Camden, Marlton, Berlin, Voorhees, NJ
Our Lady of Lourdes Medical Center - Camden, NJ
Underwood Memorial Hospital - Woodbury, NJ

PROFESSIONAL AFFILIATIONS

Fellow, American College of Cardiology
Massachusetts Medical Society

TEACHING APPOINTMENTS

9/1997
Immunology Teaching Assistant
St. George's University School of Medicine
Grenada, West Indies

1993
Inner City Tutorial
The Johns Hopkins University
Baltimore, MD

BIBLIOGRAPHY

Mohapatra R, Tran M, Gore M.J., Spencer A.F.: "A Review of the Oral Direct Thrombin Inhibitor Ximelagatran: Not Yet the End of the Warfarin Era." American Heart Journal; July 2005; 150(1):19-26